Women Ages 30-39
Comparison of risk in women with LCIS/AH, ages 30-39
Click images to enlarge.
High risk women between the ages of 30-39 who have LCIS or AH, over time
High risk women between the ages of 30-39 who have LCIS or AH, over the next 30 years
Average women between the ages of 30-39 who do not have LCIS or AH, over the next 30 years
High risk women between the ages of 30-39 who have LCIS or AH and take preventive therapy, over the next 30 years
Risk Reduction Comparison
Taking preventive therapy can reduce one’s risk of developing breast cancer by up to 75%.
Possible Side Effects
These medications are associated with some side effects, but they occur infrequently.
Side effects may include:
- Tamoxifen/Raloxifene
- hot flashes
- vaginal symptoms
- Aromatase inhibitors
- hot flashes
- vaginal symptoms
- joint pains
- bone thinning
Women on Tamoxifen have fewer total cancers in their lifetime than women who are not.
Possible Rare Side Effects
- Tamoxifen/Raloxifene
- Blood clots
- Cancer of the uterus
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.